That's too dangerous imo. They should not be relying upon the FDA before securing funding of some sort to at least get us through until well into next year. Blowing $27mn on the close out costs has put us in a perilous position. Any delays and we are severely compromised.
Perhaps what FB mentioned about forward selling royalties will come to fruition. I really don't like the sound of it but beggars can't be choosers.
They seem determined to take the prime asset (Europe/US) as far as possible before dealing. I hope this isn't our downfall.
Where we at?, page-93
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.010(4.08%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $71.94K | 282.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 292445 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 59000 | 2 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
0.010 ( 4.67 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 26.0¢ | 24.5¢ | 187376 | ||
| Last updated 15.50pm 24/05/2024 ? | |||||
| PAR (ASX) Chart |